YD Bio YDES 深 沪
已收盘 08-21 16:00:00 美东时间
4.69
-0.096
-2.00%
华盛通- 最 高5.00
- 今 开4.56
- 成交量 3.60万股
- 最 低 4.40
- 昨 收 4.7858
- 总市值 3.32亿
- 52周最高 25.00
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 1.70
- 委 比 86.22%
- 总股本 7083.13万
- 历史最高 25.00
- 量 比 0.44
- 振 幅 12.54%
- 历史最低 1.70
- 每 手 1
- 风险率 5.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
YD Bio Limited, a biotech company, launched two chrono-nutrition formulations in collaboration with the Taiwan CDHA and FHI. The daytime "Golden Triangle" formula and nighttime zinc-plus-calcium formula aim to address specific nutritional needs observed by clinicians. YD Bio plans to expand this physician-partnership model to develop additional products with other healthcare organizations, focusing on building trusted relationships and creating a...
08-11 12:00
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
YD Bio, along with Numia Health, EG BioMed US, and YD Bio US, launches a six-month pilot in British Columbia, Canada, to evaluate a cross-border clinical workflow for blood-based cancer testing. The pilot will assess operational workflows, specimen logistics, and patient experience, supporting OkaiDx tests for breast, colorectal, pancreatic, liver, and gastrointestinal cancers. Conducted at EG BioMed US’s CLIA-certified lab in Washington, the ini...
07-28 12:00
美股牛股 | IREN升逾13%！此前获Anthropic数据中心候选资格；高性能计算公司SHAZ涨近18%
IREN升逾13%！获Anthropic数据中心候选资格；商业媒体公司CRTO升逾21%，获溢价50%收购要约；高性能计算公司SHAZ涨近18%，此前完成16亿美元重磅战略融资>>
07-07 19:04
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
YD Bio Limited announced that its affiliate, EG BioMed US Inc., has obtained clinical laboratory licenses in Rhode Island and Pennsylvania, expanding its CLIA-certified, CAP-accredited laboratory's reach to 46 U.S. states. This expansion enhances patient access to blood-based cancer detection services and supports the Company's transition to a platform-based biotechnology company focused on real-world molecular data. The laboratory's growth is se...
07-02 12:00
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday
The Dow Jones index rose 700 points, Autoliv Inc (NYSE: ALV) reported strong results causing a jump in its shares by 8.4% to $120.77. Other big gainers included CRML, ABTC, MFI, BYND, RXT, SHMD, MGRT, CWH, CRVS, ALK, YDES.
04-17 22:09
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States
Taiwanese biotechnology company YD Bio, in collaboration with EG BioMed, has launched the EG Telehealth Platform, marking a significant step in commercializing early cancer detection and clinical services across the U.S. The platform, accessible in 44 states, D.C., and Guam, integrates YD Bio's digital health solutions with EG BioMed's certified diagnostic capabilities, enabling scalable deployment and nationwide patient access. Designed for dece...
03-31 12:00
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers ENvue Medical (NASDAQ:FEED) shares increased by 59.4% to $2.28 during T...
03-25 01:05
Apogee Therapeutics, Tower Semiconductor, Norwegian Cruise Line And Other Big Stocks Moving Higher On Thursday
Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data. Satellogic (SATL), YD Bio (YDES), AXT Inc (AXTI) also see gains.
03-23 22:45
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
Taipei, Taiwan, March 17, 2026 (GLOBE NEWSWIRE) - YD Bio Limited, a biotech company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, has outlined its strategic roadmap under CEO Dr. Ethan Shen. The company is moving beyond the traditional single-asset biotech model to build an integrated healthcare ecosystem, synchronizing diagnostic intelligence with advanced therapeutic execution. Key highlights includ...
03-17 12:00
